Affinia Therapeutics locks in $60m Series A
Affinia Therapeutics, a gene therapy company, has secured $60 million in Series A financing.
Affinia Therapeutics, a gene therapy company, has secured $60 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination
